US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bayer A.G.

15.66

-0.0100-0.06%

Post-market: 15.660.00000.00%16:00 EST

Volume:544.42K

Turnover:8.52M

Market Cap:61.54B

PE:-37.45

High:15.72

Open:15.63

Low:15.60

Close:15.67

52wk High:15.98

52wk Low:7.65

Shares:3.93B

Float Shares:3.93B

Volume Ratio:0.34

T/O Rate:0.01%

Dividend:0.03

Dividend Rate:0.20%

EPS(TTM):-0.4181

EPS(LYR):-0.6723

ROE:-4.56%

ROA:4.34%

PB:1.91

PE(LYR):-23.29

Loading ...

Overview Company News Filings

Bayer’s Hemophilia A Gene Therapy Trial Reaches Completion, Signaling Next Steps for BAYRY

Bayer Sells Cancer Drug to Gruenenthal for up to $431 Million

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Bayer Expands Real World Surveillance for Darolutamide in Indian Prostate Cancer Market

Bayer granted accelerated approval for Hyrnuo by FDA

Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment

Bayer initiates Phase II study of BAY 3670549 in patients with AFib

Corn and Soybean Prices are Popping. How to Play It.

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial

Bayer Agricultural Unit's Potential Seems Underrated

Bayer announces presentation of results from Phase III REVEAL study

Bayer Tests New Sepsis Clotting Drug With Aspirin: Early Trial Signals For BAYRY Investors

Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY

Bayer (BAYRY) Gets a Hold from Berenberg Bank

Missouri Court Grants Delay for Bayer's Roundup Settlement Hearing

Bayer CEO Rules Out Group Breakup for Now

Dow Jones Top Company Headlines at 9 am ET: McDonald's Aims to Improve Service and Food, and Chose a New U.S. Boss to Help | Pfizer's ...

Bayer Q2 Adj. EPS $0.28 Beats $0.23 Estimate, Sales $12.639B Beat $12.320B Estimate

Benzinga Earnings

Global Equities Roundup: Market Talk

Bayer's Results Should be Well Received

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BAYRY/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":15.66,"timestamp":1794603600000,"preClose":15.67,"halted":0,"volume":544421,"hourTrading":{"tag":"盘后","latestPrice":15.66,"preClose":15.66,"latestTime":"16:00 EST","volume":1298,"amount":20315.940000000002,"timestamp":1794603640964,"change":0,"changeRate":0,"amplitude":0.000639},"delay":15,"changeRate":-0.000638162093171652,"floatShares":3929259738,"shares":3929696328,"eps":-0.41815,"marketStatus":"Closed","change":-0.01,"latestTime":"11-13 16:00:40 EST Delay","open":15.63,"high":15.715,"low":15.6,"amount":8523143.572799996,"amplitude":0.007339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.41815,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":15.67,"volumeRatio":0.34397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"4.34%","roe":"-4.56%","lyrEps":-0.672343,"volumeRatio":0.34397,"shares":3929696328,"dividePrice":0.031526,"high":15.715,"amplitude":0.007339,"preClose":15.67,"low":15.6,"week52Low":7.65,"pbRate":"1.91","psRate":"1.22","week52High":15.98,"institutionHeld":0.0017,"latestPrice":15.66,"eps":-0.41815,"divideRate":0.002013,"volume":544421,"delay":15,"ttmEps":-0.41815,"open":15.63,"prevYearClose":10.82,"prevWeekClose":15.33,"prevMonthClose":13.99,"prevQuarterClose":13.5,"fiveDayClose":15.33,"twentyDayClose":12.47,"sixtyDayClose":14.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"","actualEps":null},{"date":"2026-04-28","symbol":"BAYRY","amount":0.031526,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-05-11"},{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"},{"market":"US","date":"2024-11-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"},{"executeDate":"2023-05-02","recordDate":"2023-05-03","paymentDate":"2023-05-15","value":0.6318,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1783918800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669480102","title":"Bayer’s Hemophilia A Gene Therapy Trial Reaches Completion, Signaling Next Steps for BAYRY","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480102","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480102?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:30","pubTimestamp":1790181037,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer is testing a new one-time gene therapy for adults with severe hemophil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-hemophilia-a-gene-therapy-trial-reaches-completion-signaling-next-steps-for-bayry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-hemophilia-a-gene-therapy-trial-reaches-completion-signaling-next-steps-for-bayry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163196","title":"Bayer Sells Cancer Drug to Gruenenthal for up to $431 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163196","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163196?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:09","pubTimestamp":1789992540,"startTime":"0","endTime":"0","summary":"Bayer agreed to sell rights to its cancer drug Stivarga to Gruenenthal Group for up to 375 million euros , the acquirer said Monday.The drug, due to lose patent protection in the European Union in 2029 and in the U.S. a year later, is approved to treat advanced forms of metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumors, German drugmaker Gruenenthal said.For Bayer, the deal comes after the German agricultural-and-pharmaceutical group completed the sale of a minority stake in its long-acting reversible contraceptives business to Apollo for around 3 billion euros earlier this month.Gruenenthal said the acquisition marks the latest step in its strategy to acquire established drugs that serve continuing medical needs. The company said it expects the acquisition to lift its 2027 earnings before interest, taxes, depreciation and amortization by up to around 100 million euros.The deal is expected to close by the end of 2026 or early 2027, subject to cus","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IBB","BK4585","MEDI","BK4588","TECB","MRNY","LABU","XLVX","GDOC","NVIB","MRNX","BBP","BK4007","BMED","GNMX","PINK","FRTY","PSCH","BAYRY","SYNB","IYH","IEIH","TBXU","LFSC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597359","title":"Bayer Expands Real World Surveillance for Darolutamide in Indian Prostate Cancer Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597359?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:31","pubTimestamp":1789057889,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer AG (BAYRY) is launching a new observational study in India to track re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayer-expands-real-world-surveillance-for-darolutamide-in-indian-prostate-cancer-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayer-expands-real-world-surveillance-for-darolutamide-in-indian-prostate-cancer-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561757","title":"Bayer granted accelerated approval for Hyrnuo by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666561757?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:30","pubTimestamp":1789032610,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that following Priority Review and Breakthrough Therapy Designation, the FDA has granted accelerated approval for Hyrnuo, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-granted-accelerated-approval-for-hyrnuo-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-granted-accelerated-approval-for-hyrnuo-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4007","BK4588","BK4585","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858537","title":"Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858537","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:55","pubTimestamp":1788980100,"startTime":"0","endTime":"0","summary":"Bayer received accelerated approval from the Food and Drug Administration for its treatment of non-small cell lung cancer.The FDA approved sevabertinib as a first-line treatment for patients with adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538313","title":"Bayer initiates Phase II study of BAY 3670549 in patients with AFib","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538313","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538313?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:45","pubTimestamp":1788954315,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced the initiation of a global Phase II clinical trial evaluating BAY 3670549, an investigational highly selective G-protein-co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-initiates-phase-ii-study-of-bay-3670549-in-patients-with-afib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-initiates-phase-ii-study-of-bay-3670549-in-patients-with-afib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MEDX","IDNA","HYLG","BAYRY","BAY","NVIB","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665355862","title":"Corn and Soybean Prices are Popping. How to Play It.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665355862","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665355862?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:55","pubTimestamp":1788540900,"startTime":"0","endTime":"0","summary":"Commodities have rallied this year and agricultural products have joined the party in the past month.That could translate into higher food prices and overall inflation, complicating the job of the Fed","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0612318971.USD","PBJ","LU0130102774.USD","CORN","LU0130517989.USD","LU2211817866.USD","SDCI","LU0654597011.USD","WEAT","BAYRY","BK4585","VEGI","BCI","LU0345781412.USD","LU0345780950.USD","LU0300736492.USD","BK4588","LU1506573853.SGD","LU1201861249.SGD","LU0477156953.USD","PYZ","LU0300736062.USD","LU1430597077.USD","MOO","LU0648001328.SGD","LU0630314457.HKD","RJI","BK4007","LU0980610538.SGD","LU0612318385.USD","CTVA","BK4535","DBA","SG9999002521.SGD","BK4093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664280587","title":"Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664280587","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664280587?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:32","pubTimestamp":1788453158,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY), Oric Pharmaceuticals Inc ($ORIC) announced an update on their ongoing clinical study. Himalayas-1 pushes Bayer AG (BAYRY) and Or...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/himalayas-1-bayer-and-oric-double-down-on-prostate-cancer-with-new-phase-3-combo-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/himalayas-1-bayer-and-oric-double-down-on-prostate-cancer-with-new-phase-3-combo-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAYRY","BK4007","BK4139","ORIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787327","title":"Bayer Agricultural Unit's Potential Seems Underrated","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787327?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:56","pubTimestamp":1788429360,"startTime":"0","endTime":"0","summary":"0955 GMT - Bayer sees its agricultural business on track to hit 2029 targets set a couple of years ago, but the market doesn't seem to be fully grasping the unit's potential, analysts at J.P. Morgan say in a research note. At an event held Wednesday, the German conglomerate reiterated its 2029 forecast for its agricultural division, with incremental sales of 3.5 billion euros over the 2024-29 period and an improvement in its underlying Ebitda margin to the mid-20s percentage range. The outlook confirmation is encouraging, because the unit's potential is undervalued by the market and consensus estimates for 2029 sales and underlying Ebitda are short of what Bayer's guidance implies by 3% and 9%, respectively, according to JPM. Bayer shares fall 0.5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663475890","title":"Bayer announces presentation of results from Phase III REVEAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2663475890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663475890?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:20","pubTimestamp":1788121214,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-announces-presentation-of-results-from-phase-iii-reveal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-announces-presentation-of-results-from-phase-iii-reveal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745191","title":"Bayer Tests New Sepsis Clotting Drug With Aspirin: Early Trial Signals For BAYRY Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745191","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745191?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:30","pubTimestamp":1787761834,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Bayer AG (BAYRY) is running an early-stage study called “Open-label Randomiz...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayer-tests-new-sepsis-clotting-drug-with-aspirin-early-trial-signals-for-bayry-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayer-tests-new-sepsis-clotting-drug-with-aspirin-early-trial-signals-for-bayry-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661975236","title":"Bayer’s Adempas Trial Update: What a Terminated Heart-Lung Study Means for BAYRY","url":"https://stock-news.laohu8.com/highlight/detail?id=2661975236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661975236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243423,"startTime":"0","endTime":"0","summary":"Bayer AG ($BAYRY) announced an update on their ongoing clinical study. Study Overview: Bayer has updated results from a terminated Phase 2 trial of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bayers-adempas-trial-update-what-a-terminated-heart-lung-study-means-for-bayry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bayers-adempas-trial-update-what-a-terminated-heart-lung-study-means-for-bayry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC","BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660184454","title":"Bayer (BAYRY) Gets a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2660184454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660184454?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:35","pubTimestamp":1787031323,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst maintained a Hold rating on Bayer yesterday and set a price target of $15.50. The company’s shares closed yesterday at $13.8...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bayer-bayry-gets-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bayer-bayry-gets-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657691543","title":"Missouri Court Grants Delay for Bayer's Roundup Settlement Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657691543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657691543?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:55","pubTimestamp":1786082100,"startTime":"0","endTime":"0","summary":"A Missouri court granted a request to postpone to Sept. 14 a hearing to  consider the final approval of Bayer's proposed $7.25 billion class settlement over its Roundup weedkiller, the company said.Bayer and the class counsel filed a joint motion with the St. Louis city circuit court earlier in the week to reschedule the hearing, which had been previously scheduled for Aug. 19.The court's order will give the parties more time to go through requests from plaintiffs to revoke their decisions to opt out of the settlement, as well as opt-out invalidity challenges, Bayer said.The company previously said some plaintiffs who had opted out of the settlement sought to revoke their decisions after the U.S. Supreme Court sided with Bayer in a case over claims that it failed to warn consumers about Roundup's potential cancer risks.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656551194","title":"Bayer CEO Rules Out Group Breakup for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2656551194","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656551194?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:30","pubTimestamp":1785850200,"startTime":"0","endTime":"0","summary":"Bayer's Chief Executive Bill Anderson ruled out a breakup of the group's operations for now, saying the company still has work to do before it can consider options.The German conglomerate is focused o","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656493559","title":"Dow Jones Top Company Headlines at 9 am ET: McDonald's Aims to Improve Service and Food, and Chose a New U.S. Boss to Help | Pfizer's ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2656493559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656493559?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:00","pubTimestamp":1785848400,"startTime":"0","endTime":"0","summary":"McDonald's Aims to Improve Service and Food, and Chose a New U.S. Boss to HelpThe Golden Arches has been working to win back customers as Americans cut spending, especially lower-income consumers.----","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","ERET","BK4501","LU1035773651.USD","SG9999002224.SGD","LU2168564495.EUR","LU1934455863.HKD","LU0868494708.USD","RWR","LU0265550946.USD","XLV","LU1061106388.HKD","LU0496365809.HKD","LU0256863811.USD","FHLC","SG9999001176.SGD","LU2433249047.HKD","CMI","CLIM","LU0965508806.USD","LU1883839398.USD","HRTS","LU1989771016.USD","LU1718418525.SGD","SG9999014567.USD","LU2125909247.SGD","LU1585245621.USD","IE00BJTD4N35.SGD","IE0002270589.USD","LU0289960550.SGD","LU0795875086.SGD","LU2360107168.USD","VNQ","BK4109","IE00BFSS8Q28.SGD","EXI","PPTY","LU0648001328.SGD","LU0225284248.USD","PBJ","PFE","LU2357305700.SGD","LU0965509101.SGD","LU0385154629.USD","LU1732800096.USD","LU1989772840.SGD","LU2211817866.USD","SG9999001176.USD","PAWZ","SPRE","HSBH","LU0211326755.USD","LU0154245756.USD","LU1066051498.USD","BK4171","IE00BJT1NW94.SGD","LU2125154935.USD","MCD","IE00B19Z3581.USD","IE00BJJMRX11.SGD","LU1668664300.SGD","LU1057294990.SGD","00005","KMB","LU2125909593.SGD","LU0006061336.USD","HWAY","SPOG","LU1280957306.USD","LU0130102774.USD","LU0289739699.SGD","JDOC","IE00BJJMRZ35.SGD","LU0456855351.SGD","TFNS","BK4550","LU1894683348.USD","LU2362540622.SGD","DD","FTXO","BK4524","KBWB","SG9999015341.SGD","LU0048573561.USD","LU0683600562.USD","LU2106854487.HKD","LU2347655073.USD","UXI","LU1066051811.HKD","SGXZ57979304.SGD","LU1861220033.SGD","LU0203347892.USD","INDS","CAT","LU0058720904.USD","BK4189","LU1162221912.USD","LU2133065610.SGD","RSPS","LU0154245673.USD","LU0234572021.USD","LU2360106780.USD","LU1506573853.SGD","SG9999001440.SGD","BK4568","IE0009355771.USD","LU0128525929.USD","LU1941712348.USD","BK4548","CRED","LU0868494617.USD","LU1917777945.USD","RNTY","LU0912757837.SGD","LU0310800379.SGD","BK4224","BK4504","BK4532","LU0052756011.USD","FREL","LU0976567544.SGD","LU2089984988.USD","LU2324357040.USD","LU2347655156.SGD","LU0211331839.USD","LU2543165471.USD","LU1430594728.SGD","LU0742534661.SGD","BK4610","LU0175139822.USD","LU0689626769.HKD","LU1571399168.USD","LU0640476718.USD","LU2360032135.SGD","XLRE","LU0162691827.USD","LU0208291251.USD","LU0070302665.USD","IE00B19Z3B42.SGD","LU2362541273.HKD","LU1804176565.USD","BK4604","SG9999002232.USD","WFC","LU1267930573.SGD","LU0122379950.USD","LU1093756168.USD","LU1929549753.HKD","IE00BLSP4239.USD","ICF","LU0057025933.USD","LU2112291526.USD","MADE","LU0211327993.USD","LU0985481810.HKD","IE00BBT3K403.USD","AVRE","PSR","LU0069063385.USD","IE0002141913.USD","BK4566","LU0965509010.AUD","BK4149","LU1548497426.USD","LU2264538146.SGD","BK4007","USRT","BK4209","DPRE","LU0321505439.SGD","IHE","TRUH","HSBC","GQRE","BK4516","LU0980610538.SGD","BBRE","W","LU1023059063.AUD","LU1267930227.SGD","LU1894683264.USD","TRUR","LU2596442595.SGD","LU0251142724.SGD","IE00B4R5TH58.HKD","LU0310799852.SGD","LU0130517989.USD","LU1829250122.USD","LU0320765489.SGD","LU2290526834.HKD","BK4567","LU0128525689.USD","SG9999014575.USD","IE00B2B36J28.USD","LU0300736062.USD","FTXG","LU0029864427.USD","BK4559","LU2463526074.USD","SG9999003800.SGD","LU0106831901.USD","BK4597","DFGR","LU0154236417.USD","BK4108","BK4555","BK4599","SG9999011175.SGD","LU0098860793.USD","LU0225771236.USD","LU0124676726.USD","BP","IE00BJTD4V19.USD","LU2357627491.SGD","LU1934455194.USD","LU0985320562.USD","SG9999015358.SGD","LU1852331112.SGD","LU0265550359.USD","BK4122","BK4571","LU2279689827.SGD","URE","LU2468319806.SGD","LU0211326839.USD","LU1814569148.SGD","LU0266013472.USD","LU2361044865.SGD","LU0006306889.USD","LU1983260115.SGD","LU2362541513.USD","LU1116320737.USD","BK4178","BAYRY","LU2361045086.USD","LU1037948541.HKD","BMED","GASZ","LU0726765562.USD","LU1069347547.HKD","LU0238689110.USD","RWO","LU0965509283.SGD","LU0310800965.SGD","DFAR","IYH","DTRE","LU1201861249.SGD","SG9999014559.SGD","LU1244550577.SGD","LU0971096721.USD","LU1066051225.USD","LU0511384066.AUD","IYR","BK4588","JPRE","IE00B7SZLL34.SGD","VGSR","LU2168563687.JPY","LU0203345920.USD","BPH","LU0786609619.USD","LU0823416689.USD","LU0861579265.USD","LU0072461881.USD","BK4581","LU1699723380.USD","TRUI","IE00BFSS7M15.SGD","LU0795875169.SGD","BK4585","BK4099","VHT","LU0289961442.SGD","LU2168564149.EUR","IXJ","SG9999014542.SGD","BK4520","LU0787776722.HKD","LU0321505868.SGD","LU1791807156.HKD","LU2023250504.SGD","LU0432979614.USD","BK4534","LU0320765646.SGD","LU1116320901.HKD","LU1941712264.USD","LU1244550494.USD","LU0056508442.USD","LU2098885051.SGD","IE00BN8TJ469.HKD","LU1093756325.SGD","VEGI","RXL","IE0004445015.USD","LU0314106906.USD","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU2125154778.USD","LU0942090050.USD","FTXH","SPOT","LU0149725797.USD","LU2491050071.SGD","ADM","BK4521","BK4207","LU0300736492.USD","LU0471298777.SGD","LU1720051108.HKD","IYF","LU1861215975.USD","LU2461242641.AUD","JRE","LU0306807586.USD","LU2168564065.EUR","IE00BD6J9T35.USD","IE00B3T34201.USD","LU1923622614.USD","LU1363072403.SGD","LU0306806265.USD","LU1934455277.USD","IYRI","LU0477156953.USD","LU0417517546.SGD","LU1303367103.USD","LU2023250843.SGD","IE00B7KXQ091.USD","MRK","LU0708994859.HKD","OZEM","BK4533","LU2265009873.SGD","LU0289739343.SGD","LU0106261372.USD","LU2250418816.HKD","LU1974910355.USD","LU1267930490.SGD","SG9999013999.USD","03160","LU2491049909.HKD","LU2491050154.USD","LU1244550221.USD","IE00BSNM7G36.USD","BK4018","BK4592","LU2168564222.USD","LU2361044949.HKD","REET","LU0859254822.USD","IE00BLSP4452.SGD","PLD","IE00B1BXHZ80.USD","LU0170899867.USD","PPH","RSHO","LU2237438978.USD","REIT","LU0472753341.HKD","LU1066053197.SGD","TM","LU1064131342.USD","LU1989772923.USD","GDOC","LU2236285917.USD","BK4201","BK4561","SCHH","LU1988902786.USD","LU0211328371.USD","LU1291159041.SGD","FRI","RITA","LU0251131958.USD","LU1074936037.SGD","LU1732799900.SGD","IE000M9KFDE8.USD","LU1037948897.HKD","LU1720051017.SGD","LU0267386448.USD","WTRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656538177","title":"Bayer Q2 Adj. EPS $0.28 Beats $0.23 Estimate, Sales $12.639B Beat $12.320B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656538177","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656538177?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:10","pubTimestamp":1785827458,"startTime":"0","endTime":"0","summary":"Bayer (OTC:BAYRY) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.23 by 21.74 percent. This is a 20 percent decrease over earnings of $0.35 per share from the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60896065/bayer-q2-adj-eps-0-28-beats-0-23-estimate-sales-12-639b-beat-12-320b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656653885","title":"Global Equities Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2656653885","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656653885?lang=en_us&edition=fundamental","pubTime":"2026-08-04 14:48","pubTimestamp":1785826080,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.0647 GMT - Bayer reported strong results for the second quarter and reiterated its full-year ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366334578.USD","BK4007","LU0211977185.USD","LU0516422952.EUR","LU0516423174.USD","LU0594300419.USD","01908","BK6108","LU1242518931.SGD","LU0979878070.USD","BK6011","LU1366334651.USD","LU0516422366.SGD","HK0000320223.HKD","HK0000320264.USD","BK4196","LU1152091754.HKD","BK1521","LU0048580855.USD","LU1152091168.USD","LU0067412154.USD","C2PU.SI","LU0072913022.USD","BK1555","LU0501845795.SGD","LU0359201612.USD","LU0264606111.USD","LU0348827113.USD","LU0605514214.HKD","BK6134","LU0048597586.USD","LU2088748020.USD","BK1589","SG9999009997.SGD","LU0417516902.SGD","BK1240","LU0594300179.USD","LU0287142896.SGD","LU0880133367.SGD","LU0516422440.USD","IE00B3M56506.USD","BK6072","LU0516423091.SGD","LU0650527681.SGD","HK0000306685.HKD","LU2088747725.USD","LU0738912210.USD","BAYRY","LU0173614495.USD","CRBJY","LU2088748293.HKD","SG9999010052.SGD","LU1807302812.USD","IE0008368742.USD","LU1993786604.SGD","N2IU.SI","LU0251144936.SGD","01109","HK0000306701.USD","LU1960683339.HKD","LU0791591158.USD","LU1880383366.USD","SG9999014674.SGD","LU0561508036.HKD","LU3063872942.SGD","LU1023057109.AUD","LU2088748376.SGD","LU0414403682.SGD","LU0572939691.SGD","LU0348825331.USD","LU1242518857.USD","LU0791590937.USD","LU0359202008.SGD","LU2088747998.USD","LU1008478684.HKD","SG9999010078.USD","BK6512","FMS","BK1570","BK6137","LU0572940350.SGD","LU0370786039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656580058","title":"Bayer's Results Should be Well Received","url":"https://stock-news.laohu8.com/highlight/detail?id=2656580058","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656580058?lang=en_us&edition=fundamental","pubTime":"2026-08-04 14:48","pubTimestamp":1785826080,"startTime":"0","endTime":"0","summary":"0647 GMT - Bayer reported strong results for the second quarter and reiterated its full-year guidance, which should be well received by investors, analysts at J.P. Morgan say in a research note. The German agriculture and pharmaceutical conglomerate reported quarterly sales and adjusted earnings that exceeded consensus expectations, and its crop-sciences and pharma divisions--the group's biggest--both beat forecasts, the analysts say. Bayer also reiterated its annual outlook at constant currency and, given that consensus estimates currently sit below the company's guidance, analysts could raise their expectations as a result, JPM says. Bayer shares are likely to outperform Tuesday, the analysts add.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}]}}